Background Kidney injury molecule-1 (Kim-1) has been validated as a urinary biomarker for
rather than injury or stress specific to kidney cells. [13] [14] [15] Recent studies investigated the use of measuring the mRNA expression or protein levels of Kim-1 and other biomarkers to detect nephrotoxicity in vitro. [16] [17] [18] However, Kim-1 expression was not markedly induced after cisplatin treatment in immortalized human cell lines such as human kidney-2 cells (HK-2) or immortalized renal proximal tubular epithelial cells (IM-PTECs). 19, 20 To date, immortalized kidney cell lines, in which Kim-1 expression is reproducibly activated in response to cisplatin, have not been reported under monolayer culture conditions.
Hosoyamada et al. 21 and Takeda et al. 22 reported immortalized mouse S1, S2 and S3 cell lines from transgenic mice harboring temperature sensitive Simian virus 40 (SV40) T antigen. In their studies, the proximal tubule region (S1, S2 and S3) of the kidney was microdissected and cell lines from each segment were established. 21, 22 These cells were shown to partially retain some kidney characteristics 23, 24 and were used in nephrotoxicity studies. [25] [26] [27] S3 cells were shown to be more sensitive to cisplatin compared to S1 or S2 cells, which is consistent with the S3 segment of rat kidney being more susceptible to cisplatin compared to the S1 and S2 segments. 21, 23, 28, 29 The mouse artificial chromosome (MAC) is derived from mouse chromosome 11 and was established by deleting known or predicted genes via telomere truncation methods. 30 MAC is maintained in cells as an independent chromosome. Therefore, it has unique characteristics and comprises a large fragment. In addition, introduced fragments containing adequate cis-elements are assumed to be intrinsically expressed. Because genes in the MAC are not integrated into random loci in the host genome, they are less affected by surrounding chromatin states than genes in other vectors, such as conventional plasmids and retrovirus. 31, 32 Moreover, reporter expression from MAC is similar among independent cell clones that contain the same reporter genes, 31 and this feature is beneficial to establishing reporter cells. We employed a MAC vector containing Kim-1 and Hprt reporter genes in the present study.
| MATERIALS AND METHODS

| Cell culture, compound treatment and cell viability assay
Immortalized mouse S1, S2 and S3 cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM)/F-12 (Gibco, Gaithersburg, MD, USA) supplemented with 1 μg/ml insulin (Sigma, St Louis, MO, USA), 10 μg/ml transferrin (Gibco), 10 ng/ml recombinant human epidermal growth factor (Peprotech, Rocky Hill, NJ, USA), 5% fetal bovine serum (FBS), 100 U/mL penicillin and 100 μg/mL streptomycin. 21 Cells were maintained in 5% CO 2 at 33°C. A9 cells with multiple integration site-containing mouse artificial chromosome (MI-MAC)
were cultured in DMEM supplemented with 10% FBS and penicillin/ streptomycin at 37°C.
Cisplatin (Wako Pure Chemicals, Osaka, Japan) was dissolved in saline (5 mM) at the time of use. Gentamicin, acetaminophen (AAP) and mannitol were purchased from Wako Pure Chemicals or Sigma, and were dissolved in culture medium (50 mg/ml), DMSO (1 M) and water (1 M), respectively. Cells were seeded at density of 2-10 × 10 4 / well in a 96-well cell culture plate (#165306; Thermo Scientific, Rochester, NY, USA), 24 h prior to assay initiation. Time PCR System (Applied Biosystems, Carlsbad, CA, USA). We generated standard curves using a dilution series of cDNA for quantification.
PCR primers are listed in the Supporting information (Table S1 ).
| Reporter construction and microcell-mediated chromosome transfer (MMCT).
Detailed procedures for the construction of a MAC vector containing mouse Kim-1 reporter gene are described in the Supporting information (Doc. S1). Details on the mouse Hprt reporter gene have been described previously. 33 were carried out to confirm the retention of the reporter MAC. 36 PCR primers are listed in the Supporting information (Table S2 ).
| Luciferase assay
We used a cell culture-treated black well plate (#655090; Greiner, Frickenhausen, Germany) for the luciferase assays. Cells were treated with chemicals and washed with PBS, and then culture medium (50 μl) and an equal volume of Tripluc Luciferase Assay Reagent (Toyobo) were added to the cells. Different wavelengths of luciferase activities from SLG and SLR3 were measured using a Phelios luminometer (ATTO, Tokyo, Japan) equipped with a spectral filter. 38 Transmission coefficients of SLG and SLR3 for the F2 (R60) filter were 0.0868 and 0.5817, respectively. At least three independent wells were used to determine the luciferase activity.
3 | RESULTS
| Cisplatin represses the cell growth of immortalized S3 cells
We first investigated the cellular toxicity of cisplatin, AAP, gentamicin and mannitol in immortalized S1, S2 and S3 cells. We also used A9 (fibroblast) cells, which are not derived from kidney and which are tumorigenic in nude mice. 39 We incubated the cells with com- substrates in response to metabolism in living cells. 40 Cisplatin is a widely used chemotherapeutic drug for various cancers that is often limited by its side effect of nephrotoxicity, especially at concentrations greater than 20 μM in the plasma. 41, 42 AAP is not only a hepatotoxicant, but also is nephrotoxic. 43 Repeated gentamicin treatment for more than 1 week induced kidney injury in rats. 11, 12 We used mannitol as a negative control because it does not induce nephrotoxicity in general. As shown in Figure 1 , S3 cells were more sensitive to cisplatin compared to S1 and S2 cells and showed a similar susceptibility to A9 cells. At 10 μM of cisplatin, the growth of S1 and S2 cells was 
| Cisplatin enhances Kim-1 gene expression in S3 cells
The expression of Kim-1 mRNA was previously reported to be markedly induced in rats in response to renal injury caused by cisplatin. 10, 11 We We also examined the time course expression of Kim-1 mRNA after cisplatin treatment. We seeded S3 cells and, after 24 h, we added cisplatin and incubated the cells for an additional 12, 24, 48 and 72 h. Figure S1 ). These results are in agreement with previous studies reporting that robust Kim-1 mRNA and protein induction was observed after 48-72 h of cisplatin treatment in the rat kidney. 10, 11, 48 We also examined Kim-1 protein expression in S3 cell lysate using western blotting (see Supporting information, Figure S2 ). The expression of Kim-1 full-length protein in cell lysate showed a similar time course trend as Kim-1 mRNA (see Supporting information, Figure S1) when we used Kim-1 antibody raised against the middle part of Kim-1 protein (see Supporting information, Figure S2 ). under the control of mouse Kim-1 promoter to detect nephrotoxicity more easily. Because little information regarding Kim-1 gene regulation has been reported, 49, 50 we used a relatively long mouse genomic sequence comprising the putative Kim-1 promoter region that should FIGURE 4 Cisplatin augments the expression of Kim-1 reporter gene in S3 cells. S3 cells that harbored stable Kim1-SLG and Hprt-SLR3 reporters were incubated with chemicals at the indicated concentrations for 72 h, and luciferase assays were performed (A and B). Luciferase activities measured by luminometer are indicated (A). SLG counts were divided by SLR3 counts and the relative activity was defined as 1 at 0 μM (B). Reporter S3 cells were incubated with cisplatin or gentamicin for 16 h and luciferase activity was determined at 72 h after the addition of chemicals (C). Luciferase counts upon cisplatin treatment are shown (left). Relative luciferase activity normalized by Hprt-SLR3 is shown (right). Error bars indicate the SD be conserved in mammals (see Supporting information, Figure S3 ).
We also used a mouse Hprt promoter-fused SLR3 (red luciferase) reporter for normalization. These two reporters were inserted into the MAC in A9 cells using a multi-integrase system (Figure 3 ; see also Supporting information, Figure S1 -S5). 30, 33, 37 We transferred the reporter-containing MAC into S3 cells and selected G418 resistant clones. We confirmed these clones by genomic PCR and FISH to demonstrate that transferred MAC retained Kim-1 and Hprt reporter genes ( Figure 3 ) and used a representative clone for subsequent assays.
3.4 | Kim-1 reporter gene is activated in cisplatintreated S3 cells We found that continuous 48-h cisplatin treatment (10-25 μM)
only moderately (by two-to eight-fold) activated the Kim-1 reporter
Kim-1 gene reporter does not respond to cisplatin in A9 cells. A9 cells that contained Kim-1 and Hprt reporter genes were incubated with chemicals for 72 h and subjected to a luciferase assay as shown in Figure 4A and 4B gene (48 h in the Supporting information, Figure S6 A and S6B). In parallel, we washed chemically-treated cells with PBS 6 h after the addition of compound, and incubated cells with fresh medium for a further 42 h (6 h in the Supporting information, Figure S4 
| DISCUSSION
In the present study, we demonstrated that Kim-1, which has been identified as an in vivo biomarker for nephrotoxicity, could be used as an in vitro biomarker for the assessment of renal toxicity induced by cisplatin in S3 cells. To date, cisplatin has failed to induce Kim-1 mRNA expression in most immortalized kidney cell lines, such as HK-2 and IM-PTECs, although cisplatin causes cytotoxicity as measured by MTT (or related) assays in these cell lines. 19, 20 We also demonstrated that Kim-1 protein expression was upregulated after cisplatin treatment for 72 h in S3 cells (see Supporting information, Figure S2 ). Because Kim-1 protein expression in S3 cell lysates, as well as Kim-1 mRNA (Figures 2; see also Supporting information, Figure S1 ), was at high levels in the control sample (0 μM of cisplatin) at 12-24 h, Kim-1 expression was considered to be also associated with dedifferentiation of kidney cell caused by proliferation.
We report that a combination of Kim-1 and Hprt reporter genes reproducibly detected cisplatin-induced nephrotoxicity in S3 cells (Figure 4) . Assays that measure cellular toxicity via MTT (or related) or apoptosis have been widely used for in vitro toxicity assays. [13] [14] [15] However, these assays mainly focus on assessing metabolic activity and cell death rather than renal cell injury or stress. (Figures 2 and 4 ). This is not unexpected because the repeated administration of gentamicin (for more than 1 week) was reported to be required for Kim-1 induction in rats. 11, 12, 51 In the case of NKi-2 cells, gentamicin treatment for 3-5 days induced cell damage when the cells formed a kidney-like structure (3D culture) in vitro. 52 These reports imply that a longer incubation time and complex cell-cell interactions may be required for gentamicin to induce nephrotoxicity. Therefore, we consider that a reduction of Hprt-SLR3 activity by high concentrations of gentamicin treatment should be caused by relatively nonspecific cytotoxicity in S3 cells ( Figure 4A ).
This speculation is consistent with the lack of Kim-1 reporter gene activation after gentamicin treatment for 72 h ( Figure 4B ), which was similar to that using A9 cells ( Figure 5 ).
In the present study, we identified the promoter region of mouse Kim-1, at least partially, and developed a Kim-1 gene luciferase reporter in conjunction with an Hprt gene reporter to detect cisplatin-induced nephrotoxicity in immortalized mouse kidney S3 cells in vitro. We demonstrated that Kim-1, which was identified as an in vivo biomarker for nephrotoxicity, was useful for the in vitro assessment of cisplatin-induced renal toxicity of S3 cells. These results
should aid the mechanistic analysis of cisplatin-induced nephrotoxicity and might also help with the development of a method for assessing the nephrotoxicity of novel drugs in vitro.
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